A recent study carried out by a research team from the Paul-Ehrlich-Institut investigated the immunomodulating properties of ...

Allogeneic dendritic cells provide both ‘stranger’ and ‘danger’ signals to the immune system that are crucial for it to sense a cell-associated threat such as cancer. These signals ...

The results indicate that β-glucans can target the immune system and modulate pro-inflammatory responses. Their potential to suppress allergic reactions and offer new approaches to allergy treatment ...

Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...

Psoriasis, a painful and uncomfortable inflammatory skin condition that affects millions worldwide, flares up from the ...

Finding offers potential new target for treatmentPsoriasis, a painful and uncomfortable inflammatory skin condition that ...

A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod.

known as conventional type 1 dendritic cells (cDC1s). These cells, located in parts of the gut like the ileum, can activate ...

Researchers at MedUni Vienna have developed a combination therapy using systemic interferon-I and topical imiquimod.

the innate immune system, consists of a variety of cell types, including natural killer (NK) cells, macrophages and dendritic cells, that serve as an initial line of defense against threats.

Effective for local tumors and distant metastases Immunotherapies use the body's own immune system to fight cancer cells. Plasmacytoid dendritic cells (pDCs), which are activated by Imiquimod via ...

This work could advance the understanding of immune system responses and pave the way for improved vaccines and immunotherapies ...